(Q68559328)
Statements
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen (English)
D R Parkinson
R I Fisher
A A Rayner
E Paietta
K A Margolin
G R Weiss
J W Mier
M Sznol
E R Gaynor
1 October 1990